Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision		 Previous revision
gabapentin [2017/05/16 21:29] – [Gastrointestinal] Scott Larsongabapentin [2017/05/16 21:31] (current) – [References] Scott Larson
Line 31: Line 31:
 ==== Genitourinary ==== ==== Genitourinary ====
  
-Common (1% to 10%): Incontinence, impotence +  * Common (1% to 10%): Incontinence, impotence 
-Uncommon (0.1% to 1%): Hematuria, dysuria, urinary frequency, cystitis, urinary retention, vaginal hemorrhage, amenorrhea, dysmenorrhea, menorrhagia +  * Uncommon (0.1% to 1%): Hematuria, dysuria, urinary frequency, cystitis, urinary retention, vaginal hemorrhage, amenorrhea, dysmenorrhea, menorrhagia 
-Frequency not reported: Breast hypertrophy, gynecomastia, sexual dysfunction (including changes in libido, ejaculation disorders, and anorgasmia)+  * Frequency not reported: Breast hypertrophy, gynecomastia, sexual dysfunction (including changes in libido, ejaculation disorders, and anorgasmia)
  
 ==== Hematologic ==== ==== Hematologic ====
  
-Common (1% to 10%): Leucopenia, purpura +  * Common (1% to 10%): Leucopenia, purpura 
-Uncommon (0.1% to 1%): Anemia, lymphadenopathy +  * Uncommon (0.1% to 1%): Anemia, lymphadenopathy 
-Rare (less than 0.1%): Thrombocytopenia, thrombophlebitis, leukocytosis, lymphocytosis, increased bleeding time  +  * Rare (less than 0.1%): Thrombocytopenia, thrombophlebitis, leukocytosis, lymphocytosis, increased bleeding time  
-Frequency not reported: Blood creatine phosphokinase increased, coagulation defect+  * Frequency not reported: Blood creatine phosphokinase increased, coagulation defect
  
 ==== Hepatic ==== ==== Hepatic ====
Line 116: Line 116:
  
 ====== References ====== ====== References ======
-[[https://www.drugs.com/gabapentin.html|Drugs.com]]+[[https://www.drugs.com/monograph/gabapentin.html|Drugs.com]]
  
  
  
  ======  ======